Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- OrthoPediatrics reported a quarterly loss of $0.30 per share, beating estimates by 28.57%. - Revenues for the quarter were $44.69 million, exceeding expectations by 7.35%. - The stock has added 1% YTD compared to the S&P 500's 7.5% gain. - The company's earnings outlook indicates a Zacks Rank #3 (Hold). - Industry rank for Medical - Instruments is in the bottom 41% of Zacks industries. Price Impact Rating: bearish Impact Horizon Rating: short-term Type: Research Analysis
- OrthoPediatrics reported a quarterly loss of $0.30 per share, beating estimates by 28.57%.
- Revenues for the quarter were $44.69 million, exceeding expectations by 7.35%.
- The stock has added 1% YTD compared to the S&P 500's 7.5% gain.
- The company's earnings outlook indicates a Zacks Rank #3 (Hold).
- Industry rank for Medical - Instruments is in the bottom 41% of Zacks industries.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.